Cargando…
Balance between Protection and Pathogenic Response to Aerosol Challenge with Mycobacterium tuberculosis (Mtb) in Mice Vaccinated with TriFu64, a Fusion Consisting of Three Mtb Antigens
Tuberculosis vaccines capable of reducing disease worldwide have proven difficult to develop. BCG is effective in limiting childhood disease, but adult TB is still a major public health issue. Development of new vaccines requires identification of antigens that are both spatially and temporally avai...
Autores principales: | Sulman, Sadaf, Savidge, Benjamin O., Alqaseer, Kawther, Das, Mrinal K., Nezam Abadi, Neda, Pearl, John E., Turapov, Obolbek, Mukamolova, Galina V., Akhtar, M. Waheed, Cooper, Andrea May |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158147/ https://www.ncbi.nlm.nih.gov/pubmed/34070048 http://dx.doi.org/10.3390/vaccines9050519 |
Ejemplares similares
-
Development of an In Vitro Assay for Detection of Drug-Induced Resuscitation-Promoting-Factor-Dependent Mycobacteria
por: Loraine, Jessica, et al.
Publicado: (2016) -
Dimethyl fumarate eliminates differentially culturable Mycobacterium tuberculosis in an intranasal murine model of tuberculosis
por: Glenn, Sarah M., et al.
Publicado: (2022) -
Coupling of Peptidoglycan Synthesis to Central Metabolism in Mycobacteria: Post-transcriptional Control of CwlM by Aconitase
por: Bancroft, Peter J., et al.
Publicado: (2020) -
The Magnitude of MTB and Rifampicin Resistance MTB Using Xpert-MTB/RIF Assay Among Tuberculosis Suspected Patients in Gedeo Zone, Southern Ethiopia
por: Diriba, Kuma, et al.
Publicado: (2021) -
Using Xpert MTB/RIF
por: Nicol, Mark P., et al.
Publicado: (2013)